Quovadx Inc., a global software company, has reached an agreement to sell its CareScience division to the Premier Inc. healthcare alliance for $34.9 million. In a second and separate transaction, Quovadx has agreed to sell the rest of the company — which includes Rogue Wave Software and Integration Solutions operating divisions — to Battery Ventures, a venture capital and private equity firm.
Quovadx's purchase price, which includes the proceeds received from the CareScience sale, is $136.7 million, subject to a working capital adjustment at closing. Thus, stated Quovadx, stockholders are expected to receive $136.7 million, or $3.15 per share, a 24 percent premium when compared to the stock's closing price on March 30.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.